While previous agents focused on general clinical–genomic queries or specific pathways such as TGF-β and PI3K, AI-HOPE-JAK-STAT uniquely targets the JAK/STAT signaling axis—a critical, yet underexplored, pathway in colorectal cancer. This evidence concerns the gene SOAT1 and colorectal cancer.